PATENT CLAIM ANALYSIS

Application Number: 15935299
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["435", "440000"]

Abstract:
Engineered CRISPR-Cas9 nucleases with improved specificity and their use in genomic engineering, epigenomic engineering, genome targeting, and genome editing.

Claim (Index 59):
The fusion protein of  claim 58 , wherein the TET protein is TET1.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.27778
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15249756', '15369533', '15015947', '15935334', '15208228']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7857801658729351
- 35 USC 102 Novelty (BERT): 0.7736846843142259
- Combined Prediction Score: 0.7845706177170642
- Mean Citation Score: 1001.4406119999996
- Max Citation Score: 1382.5892
- Similarity Product: 970.3188852886676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test